NCT04393506
- Conditions
- Head and Neck Neoplasms, Inductive Therapy, Mouth Diseases, +7 more
- Locations
-
- Shanghai Ninth People's Hospital Shanghai, Shanghai Municipality, China
Clinical trial condition
Explore clinical trials studying VEGFR2 Inhibitor. Study availability and eligibility vary by location and protocol.
NCT04393506